These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15832838)

  • 1. Exploring direction of causation between social support and clinical outcome for HIV-positive adults in the context of highly active antiretroviral therapy.
    Burgoyne RW
    AIDS Care; 2005 Jan; 17(1):111-24. PubMed ID: 15832838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social support and quality of life over time among adults living with HIV in the HAART era.
    Burgoyne R; Renwick R
    Soc Sci Med; 2004 Apr; 58(7):1353-66. PubMed ID: 14759681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile.
    Burgoyne RW; Rourke SB; Behrens DM; Salit IE
    AIDS Behav; 2004 Jun; 8(2):151-63. PubMed ID: 15187477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era.
    Saunders DS; Burgoyne RW
    Int J STD AIDS; 2002 Oct; 13(10):683-90. PubMed ID: 12396538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between social support and viral load in adults on highly active antiretroviral therapy - Witbank, South Africa.
    Habte TM; Bondo C; Nkombua L
    S Afr Fam Pract (2004); 2020 Dec; 62(1):e1-e7. PubMed ID: 33314941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients.
    Bisaso KR; Karungi SA; Kiragga A; Mukonzo JK; Castelnuovo B
    BMC Med Inform Decis Mak; 2018 Sep; 18(1):77. PubMed ID: 30180893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
    Azmeraw D; Wasie B
    Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
    Kaufmann GR; Khanna N; Weber R; Perrin L; Furrer H; Cavassini M; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Antivir Ther; 2004 Apr; 9(2):263-74. PubMed ID: 15134189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy.
    Koenig LJ; Pals SL; Bush T; Pratt Palmore M; Stratford D; Ellerbrock TV
    Health Psychol; 2008 Mar; 27(2):159-69. PubMed ID: 18377134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.
    Hailu GG; Hagos DG; Hagos AK; Wasihun AG; Dejene TA
    PLoS One; 2018; 13(5):e0196259. PubMed ID: 29715323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.
    Palmisano L; Giuliano M; Nicastri E; Pirillo MF; Andreotti M; Galluzzo CM; Bucciardini R; Fragola V; Andreoni M; Vella S
    AIDS; 2005 Nov; 19(16):1843-7. PubMed ID: 16227792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.
    Crepaz N; Hart TA; Marks G
    JAMA; 2004 Jul; 292(2):224-36. PubMed ID: 15249572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
    Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
    AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral load assay sensitivity and low level viremia in HAART treated HIV patients.
    Verhofstede C; Van Wanzeele F; Reynaerts J; Mangelschots M; Plum J; Fransen K
    J Clin Virol; 2010 Apr; 47(4):335-9. PubMed ID: 20138803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection.
    Farías AA; Kremer LE; Allende L; Díaz Mdel P; Pisano MB; Contigiani MS; Ré VE
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):432-7. PubMed ID: 23761392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.